Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lisata Therapeutics (LSTA) Debt to Equity (2016 - 2017)

Lisata Therapeutics (LSTA) has disclosed Debt to Equity for 8 consecutive years, with $0.0 as the latest value for Q2 2017.

  • For the quarter ending Q2 2017, Debt to Equity fell 99.97% year-over-year to $0.0, compared with a TTM value of $0.0 through Jun 2017, down 99.97%, and an annual FY2016 reading of $0.81, up 295.73% over the prior year.
  • Debt to Equity was $0.0 for Q2 2017 at Lisata Therapeutics, up from -$1.73 in the prior quarter.
  • Across five years, Debt to Equity topped out at $1.46 in Q2 2016 and bottomed at -$1.73 in Q1 2017.
  • Average Debt to Equity over 5 years is $0.15, with a median of $0.11 recorded in 2013.
  • The sharpest move saw Debt to Equity skyrocketed 3576.0% in 2016, then plummeted 1513.57% in 2017.
  • Year by year, Debt to Equity stood at $0.01 in 2013, then soared by 2790.1% to $0.26 in 2014, then decreased by 20.94% to $0.2 in 2015, then surged by 295.73% to $0.81 in 2016, then crashed by 99.95% to $0.0 in 2017.
  • Business Quant data shows Debt to Equity for LSTA at $0.0 in Q2 2017, -$1.73 in Q1 2017, and $0.81 in Q4 2016.